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care units (1). Pathological changes associated with ALI are intense inflammation accompanied by disruption of the epithelial integrity, interstitial edema, and accumulation of neutrophils (2, 3) . The mechanism of endotoxin-induced ALI and an effective therapeutic regimen are still unknown.
Excessive inflammation is avoided through regulation by critical factors (4) . Hypoxia inducible factor 1 alpha (HIF-1a) is a transcription factor that triggers cytoprotection and metabolic alterations in response to hypoxia (5, 6) . HIF-1a induces the transcription of over 40 genes in oxygen homeostasis to diminish oxygen tension; one of the targeted genes is heme oxygenase-1 (HO-1) (7, 8) . HO-1 has been recognized to exhibit important immune modulatory and anti-inflammatory functions (9) . Hypoxia is connected to inflammation and studies show that HIF-1a is crucial for innate and adaptive immunity, particularly in cellular metabolism and oxygen delivery (10, 11) . Stabilization of HIF-1a and induction of its downstream genes have antiinflammatory effects (12, 13) .
MicroRNAs (miRNAs) are small, noncoding
RNAs of approximately 22 nucleotides that regulate gene expression through translational suppression or mRNA degradation. MiRNAs recognize target sites in 3'-untranslated regions (UTRs) with specific but imperfect pairing (14, 15) . Recently, miR-155 was shown to be critical for control of innate immunity. MiR-155 is highly induced in macrophages stimulated with toll like receptor (TLR) ligands such as poly (I: C) and lipopolysaccharide (LPS) (16) . Overproduction of miR-155 during macrophage activation promotes and sustains inflammation (17, 18) . In prolonged hypoxia, HIF-1a is a target of miR-155, with miR-155 triggering the resolution of HIF-1a (19) . Our preliminary investigation identified a sequence in the HIF-1a 3'-UTR that was highly consistent with the target sequence for the seed region of miR-155. Therefore, we hypothesized that suppression of miR-155 might derepress HIF-1a expression to attenuate the inflammatory response.
Isoflurane, a halogenated ether, is a potent inhalation agent in surgery and a sedative used in intensive care units (20) . Growing evidence shows that isoflurane has anti-inflammatory properties. It is reported to prevent cytokine secretion from macrophages after LPS challenge (21, 22) . In vivo studies showed that isoflurane protects against sepsis-induced mortality, reduces recruitment of polymorphonuclear leukocytes, decreases protein leakage in the microvasculature, and inhibits cytokine release in lung tissue (23) . In our previous study, we demonstrated that isoflurane preconditioning resulted in potent pulmonary protection. Posttreatment with isoflurane attenuates ALI by improving vascular permeability through overexpression of HO-1 (24) . However, the molecular basis and the anti-inflammatory mechanism of isoflurane effects are still poorly understood. In this study, we provide evidence that posttreatment of cells with isoflurane limits inflammatory reactions by triggering a miR-155-HIF-1a pathway, leading to upregulation of HO-1.
MATERIALS AND METHODS

Cell culture and treatment
The murine alveolar macrophage cell line MH-S was obtained from the cell repository of Shanghai Institute for Biological Science (Shanghai, China), and the mouse lung epithelial type II cell line MLE-12 was obtained from ATCC (Manassas, VA). MH-S cells were grown in 1640 medium with 10% fetal bovine serum (FBS) (Gibco), while MLE-12 cells were cultured in HITES medium with 2% FBS (Gibco) (25) . Cell medium were supplemented with 100 U/ml penicillin and 100 mg/ml streptomycin.
To determine whether posttreatment of cells with isoflurane alleviated cell injury, MH-S and MLE-12 cells were stimulated with 100 mg/ml LPS for 24 h with or without posttreatment with isoflurane (26) . The indicated cells were incubated with isoflurane (0.1.6., 0.3.2. or 0.6.4. mM; Abbott Laboratories, Abbott Park, IL) for 0 h, 2 h, 4 h, or 8 h in sealed chambers inside incubators as described previously (27) . The cells without any treatment were served as normal control.
CCK8 assay
MH-S and MLE-12 cells in logarithmic growth were digested with trypsin to single suspensions and 8000 to 10,000 cells were transferred to 96-well plates for treatment as indicated. CCK-8 (cell counting kit-8, Dojindo, Japan) was added into the 96-well plates. OD (optical density) at 450 nm was read with a microplate reader 2 to 4 h after incubating with reagent. Each experiment was performed 3 times independently.
Plasmid construction
To construct psiCHECK-HIF-1a-3'UTR-WT (wild type, WT), the 3'-UTR fragment of HIF-1a (Genebank accession: NM_010431) containing © 1996-2015 binding sites of miR-155 (from 2935 to 4775 bp in the HIF-1a mRNA), was amplified by PCR using primers 5'-AACCCTCGAGGCGTTT CCTAATCTCATT-3' and 5'-AACCGCGGCCG CAAGCTGGAAGGTTTGTG -3', and cloned into Xhol I/Not I sites of psiCHECK-2 (Gifted by Dr. Cheng-You Jia, from central laboratory of Shanghai Tenth People's Hospital of Tongji University) for simultaneous expression of firefly and renilla luciferases. The HIF-1a 3'-UTR was cloned downstream of the Renilla gene in a modified psiCHECK-Control vector. Firefly luciferase control reporter serves as the control reporter.
PsiCHECK-HIF-1a-3'UTR-mut (mutated) was generated as the same method above by mutating four nucleotides of the HIF-1a 3'-UTR in the miR-155 seed sequence at position 3971 to 3974bp, change GCAT to CGTA ( Figure 4A ). PCR primers were:
5'-ATTCTAGAGCTAGCGTTCATAATCG TTCACTCTAC-3' and 5'-TCCTTCGCGGCCG CGAGTTGAGATGTTGTTTAGG-3'. Mutations were confirmed by DNA sequencing.
Luciferase reporter assays
MH-S cells were transfected with 50 nM RNA oligonucleotides that were mmu-miR-155 mimics (5'-UUAAUGC UAAUUGUGAUAGGGGU-3') or mmu-miR-155 inhibitor (5'-ACCCCUAUCA CAAUUAGCAUUAA-3') (Genepharma, Shanghai) with psiCHECK-2 HIF-1a 3'-UTR plasmid using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. MiRNA mimics control (5'-AGTGTGAGTTCTACCATTGCCAAA-3'), miRNA inhibitor control (5'-CAGUACUU UUGUGUAGUACAA-3') and psiCHECK-2-HIF-1a 3'-UTR-mut served as controls. After transfection for 48 h, cells were washed with PBS twice and lysed with 100 ml passive lysis buffer (Promega E194A, Madison). Dual Luciferase Reporter Assay kits (Promega, Madison, WI) were used to measure luciferase activity using an illuminometer (Lumat LB 9507, Berthold, Germany). Experiments were repeated 3 times independently.
Transfection with HIF-1a siRNA
RNA interference was performed with HIF-1a siRNA or negative control siRNA (Genepharma, Shanghai). Lipofectamine 2000 (Invitrogen) was used for cell transfection according to the manufacturer's instruction. MH-S and MLE-12 cells were transfected with 50 nM siRNA at 60% confluence. After transfection for 6 h, normal growth medium was replaced. After incubation for 18 h, the cells were stimulated with 100 mg/ml LPS for 24 h, or followed with 0.32 mM isoflurane for 4 h. HIF-1a siRNA was HIF-1a-MUS-606: 5'-GCUCACCAUCAGUUAUUUATT-3', and the negative control siRNA was 5'-UUCUCCGAACGUGUCACGUTT-3'.
Gene transfection with miR-155, miR-155 EV, miR-155 inhibitor, and miR-155 inhibitor EV
The lentivirus-mediated miR-155 packaging system contained three plasmids: GV217-miR-155 (or GV217 empty vector (EV)), pHelper 1.0., and pHelper 2.0. at 4:3:2. The plasmids in the lentivirusmediated miR-155 inhibitor packaging system were GV159-miR-155 inhibitor (or GV159 EV), pHelper 1.0., and pHelper 2.0. at 4:3:2. Plasmids (12 mg) were co-transfected with 30 ml Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) into HEK-293T cells, and cultured in 10 cm diameter culture dishes. Supernatants were collected after 48 h infection and filtered with 0.45 micrometer pore filters and used as a source of virus. The final viral titer was 8 × 10 8 titre unit (TU)/ml for mmu-miR-155 and mmu-miR-155 EV, and 1 ×10 9 TU/ml for mmu-miR-155 inhibitor and mmu-miR-155 inhibitor EV.
MH-S and MLE-12 cells were infected with miR-155, miR-155 EV, miR-155 inhibitor, and miR-155 inhibitor EV with 5 mg/ml polybrene (Sigma) for 12 h, and medium was refreshed. After infection for 96 h, efficiency was evaluated with a fluorescent microscope. Cells were sorted using fluorescent activated cells sorter (FACS; Becton Dickinson, Mountain View, CA, USA) according to the GFP expression from GV217 and GV159 plasmids. Sorted cells were used for experiments. Lentiviruses (2.5 × 10 7 TU in 200 ml) were injected into mice through the caudal vein 14 days before experiments.
Animals and experimental protocols
As described previously, isoflurane was delivered via a custom-built chamber that allowed isoflurane to flow in and out of opposite ends of the chamber (28) . Mice inhaled 1.4% isoflurane, which was 1 minimal alveolar concentration (MAC) for mice, balanced with air through an isofluranespecific vaporizer (Datex-Ohmeda Inc., Madison) for 4 h. Negative and positive control animals, which received saline or LPS, were exposed to air (29) . Isoflurane and oxygen concentrations were monitored by Datex infrared analyzer (Capnomac, Helsinki, Finland) from a hole near the outlet. The concentration of inhaled anesthetic used in this study © 1996-2015 did not cause any cardiorespiratory complications in preliminary experiments.
Male C57BL/6 mice at 6-8 weeks of age used in our study were obtained from SLAC National Rodent Laboratory Animal Resource (Shanghai, China). All animals were approved by the Institutional Animal Care and Use Committee of the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine. Mice were housed in a laminar flow cabinet with a 12 h light/12 h dark cycle with free access to food and water. One hundred and sixty mice were randomized into five groups (n = 32 per group), which injected via tail veins with 2.5 × 10 7 TU miR-155, miR-155 inhibitor, miR-155-EV, or miR-155 inhibitor-EV lentiviruses respectively (30) . And mice of one group without injection of lentiviruses were used as controls (Non-injected). 14 days after injection, mice in each group were divided into four groups (n = 
Quantitative real-time PCR (Q RT-PCR)
Total RNA from cells or lung tissue were extracted with TRIzol reagent (Invitrogen, Carlsbad, CA). Single-stranded cDNAs were reverse synthesized using EasyScript cDNA synthesis kits (Applied Biological Materials), and miRNA was analyzed using TaqMan MicroRNA Reverse Transcription kits (Applied Biosystems). Q RT-PCR was performed in an ABI Prism 7900HT sequence detection system (Applied Biosystems), using KAPA SYBR FAST qPCR kit Master MIX (Lifetech, Carlsbad, CA) for miR-155 quantification and SYBR green PCR reagent kits (Clontech) to quantify HIF-1a transcription. The primers for Q RT-PCR were as follows: miR-155, forward: 5'-GCCCGTTAATGCTAATTG-3', reverse:
5'-GTGCAGGGTCCGAGGT-3'; U6, forward: 5'-CTCGCTTCGGCAGCACA-3', reverse:
HIF-1α, forward: 5'-TAAATGTTCTGCCCACCCT-3', reverse:
β-actin, forward: 5'-GAGCTACG AGCTGCC TGACG-3', reverse:
5'-CCTAGAAGCATT TGCGGTGG-3'. snRNA U6 was used as an internal control for miR-155 and β-actin for HIF-1a.
Western blot analysis
Total protein was extracted from cultured cells or mouse lung tissue using RIPA lysis buffer (50 mM Tris-HCl pH7.4, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 0.1.% SDS, 1% sodium deoxycholate, 1 mg/ml leupeptin, 1 mg/ml aprotinin and 2.5 mM sodium orthovanadate). Briefly, 50-80 μg samples were separated by SDS-PAGE and transferred to PVDF membranes. Western blot was carried out as described previously (28) . Antibodies were HIF-1a (1/500, ab113642, Abcam), HO-1 (1/1000, ab85309, Abcam) and β-actin (1/1000, A2066, rabbit polyclonal; Sigma). Bands were visualized using an enhanced chemiluminescence reagent kit (Amersham Life Science, Cleveland, OH).
The densitometric values were determined using a gel image analysis system (Bio-Rad, Hercules, CA) normalized to β-actin.
Histopathology
Mice were decapitated and lung tissue was harvested for histopathology. Pulmonary changes in morphology were determined 24 h after stimulation with LPS, with or without isoflurane. Lung tissues were fixed with 4% paraformaldehyde, embedded in paraffin, and sectioned at 4 mm at room temperature. Samples were stained with hematoxylin and eosin (H&E) and examined by light microscopy. The degree of lung injury was evaluated using a scoring system based on predetermined criteria (32) ( Table 1) . Two independent investigators read slides in a blind manner and the average scores were determined. Injury score was determined according to the formula: ((alveolar hemorrhage points/number of fields) + 2 × (alveolar infiltrate points/number of fields) + 3 × (fibrin points/number of fields) + (alveolar septal congestion/number of fields))/total number of alveoli counted.
IL-1β and TNF-a level in bronchoalveolar lavage fluid
Bronchoalveolar lavage fluid (BALF) was collected by irrigating left lungs twice with 2 ml saline at the end of experiments. After centrifuging at 200 × g for 10 min, IL-1β and TNF-α levels in BALF were determined using an ELISA kit (R&D Systems Inc., Minneapolis, MN, USA). © 1996-2015
Immunohistochemistry
Lung tissue sections (4 μm) were dewaxed in xylene, rehydrated with graded ethanol, rinsed in PBS three times for 5 minutes, and immersed in 3% hydrogen peroxide in 80% methanol for 10 min to block endogenous peroxidase activity. Slides were rinsed in PBS twice for 5 min, blocked with 5% bovine serum at 25ºC for 20 min and incubated with mice monoclonal anti-HIF-1a (Abcam, ab113642, UK; 1:200 dilution) at 4ºC overnight. Mice IgG isotype was used as a negative control. Slides were incubated with biotinylated rabbit antimouse IgG secondary antibody, and incubated with H 2 O 2 -diaminobenzidine for 1 min. Samples were counterstained with hematoxylin.
Statistical analysis
All results were means ± standard deviation (SD) of at least three independent experiments. Statistical analyses were calculated by Student's t-test or one-way ANOVA and p < 0.05 was considered significant. GraphPad Prism 6.0 software (GraphPad Software Inc., San Diego, CA, USA) was used for statistical calculations.
RESULTS
Isoflurane alleviates LPS-induced cell injury
We investigated the effects of isoflurane postconditioning in different concentrations on the viability of LPS-treated cells. MH-S and MLE-12 were stimulated with 100 mg/ml LPS for 24 h with posttreatment of 0.16 mM, 0.32 mM, or 0.64 mM isoflurane for 4 h. It was found that the cell viability increased with the concentrations of isoflurane treatment and reached the higest value at 0.32 mM ( Figure 1A, 1B) . Therefore, 0.32 mM isoflurane was used in the following experiments. To find out the protective effects of isoflurane postconditioning duration against LPS induced cell injury. MH-S and MLE-12 were stimulated with 100 mg/ml LPS for 24 h with posttreatment of 0.32 mM isoflurane for 2 h, 4 h, or 8 h. It was found that the viability of cells posttreated with isoflurane (4 h or 8 h) was significantly higher than that in the LPS-treated cells without isoflurane post conditioning (p<0.0.5.) ( Figure 1C, 1D ). These data implied that postconditioning with 0.32 mM isoflurane for 4 h and 8 h have a protective effect on LPS-induced cells. In our study, the further investigations focused on posttreatment with 0.32 mM isoflurane for 4 h.
miR-155 and HIF-1a are involved with the isoflurane effect on LPS-induced cell injury
To understand the potential mechanisms involved in the protective effects of isoflurane postconditioning against LPS-induced cell injury, we investigated the effects of isoflurane postconditioning on the levels of miR-155 and HIF-1a in MH-S and MLE-12 cells. We exposed cells to 0.32 mM isoflurane for 4 h after challenging with LPS for 24 h. The untreated cells were served as control. HIF-1a mRNA and miR-155 levels in MH-S and MLE-12 cells were determined by Q RT-PCR and the protein levels of HIF-1a were detected by western blotting. LPS treatment significantly upregulated the levels of miR-155 (Figure 2A ) and the expression of HIF-1a both in mRNA and protein ( Figure 2B , 2C) compared with the untreated control cells. However, postconditioning with isoflurane significantly downregulated the levels of miR-155 and upregulated both mRNA and protein levels of HIF-1a in LPS-challenged cells compared with the LPS treatment cells without posttreatment with isoflurane ( Figure 2 ). To further examine whether isoflurane reduced cell LPS-induced injury through HIF-1a activation, MH-S and MLE-12 cells were subjected to siRNA mediated silencing of HIF-1a ( Figure 3A) . CCK8 assay and western blots showed that silencing of HIF-1a significantly reduced the cell viability ( Figure 3B, 3C ) and downregulated the 
MiR-155 targets the HIF-1a gene
To confirm that the HIF-1a gene is a direct target of miR-155, luciferase reporter assays were performed in MH-S cells. HIF-1a wild-type (WT) or four nucleotides mutated (mut) within HIF-1a 3'UTR was cloned into a luciferase reporter vector based on the predicted binding site in the 3'UTR of HIF-1a with miR-155 seed sequence ( Figure 4A) , and co-transfected with miR-155 mimics or negative miRNA control mimics (miR-155 mimics control) or miR-155 inhibitor or negative miRNA control inhibitor (miR-155 inhibitor control) into MH-S cells. Luciferase reporter assays showed that miR-155 mimics significantly decreased the luciferase activity of the 3'UTR-WT but not that of the 3'UTR-mut of HIF-1a in MH-S. Meanwhile, inhibition of miR-155 increased the luciferase activity after the co-transfection of miR-155 inhibitor and the 3'UTR-WT of HIF-1a into cells ( Figure 4B ). These results demonstrated that HIF-1a is a potential target of miR-155 and can be directly regulated by miR-155.
MiR-155 negatively regulates the expression of HIF-1a
To further investigate whether isoflurane exerts its function by modulating miR-155 and its target gene HIF-1a in LPS-induced cell injury, MH-S and MLE-12 cells were infected with lentivirus expressing or inhibiting miR-155. Overexpression of miR-155 significantly downregulated HIF-1a expression, whereas inhibition of miR-155 significantly upregulated the expression of HIF-1a in infected cells with or without isoflurane treatment after LPS stimulation ( Figure 5 ). These results suggested that overexpression of miR-155 impaired the effect of isoflurane and inhibition of miR-155 promoted the effect of isoflurane on LPS-induced cell injury.
HO-1 is involved in the effect of isoflurane in vitro
To investigate whether the protective effect of isoflurane on LPS-induced cell injury was related to a gene downstream of HIF1-ALPHA, we measured HO-1 protein by western blot. Postconditioning with isoflurane increased HO-1 protein levels compared to the LPS-treated group ( Figure 2C ). The change trend of HO-1 protein levels were the same as HIF1-ALPHA in MH-S and MLE-12 cells with different treatment ( Figure 5C, 5D ). In addition, HO-1 protein decreased when HIF1-ALPHA was downregulated by siRNA ( Figure 3D ). We found that HIF1-ALPHA and HO-1 involved in the protective effect of isoflurane on cells treated with LPS. Overexpression of miR-155 alleviated the effect on HO-1 protein in LPS-treated cells. Downregulation of miR-155 increased HO-1 expression.
Postconditioning with isoflurane attenuates LPS-induced ALI
Twenty four hours after the administration of LPS by intraperitoneal injection, lung tissues of mice were harvested for observations of histopathological changes. The photomicrographs showed interstitial edema, intra-alveolar exudation, © 1996-2015 hemorrhage, alveolar wall thickening, and infiltration of inflammatory cells into the lung interstitium and alveolar space ( Figure 6A ). Postconditioning with isoflurane ameliorated these effects. Semiquantitative evaluation using a lung injury score (32) showed that the degree of lung injury in the LPS-Isoflurane group was lower than that in the LPS group ( Figure 6B ). To determine isoflurane effects, we measured TNF-a and IL-1β levels in BALF. Isoflurane reduced the levels of TNF-a and IL-1β, suggesting that isoflurane was essential for attenuating LPS-induced ALI ( Figure 6C, 6D ).
Inverse expression of HIF1-ALPHA and miR-155 after postconditioning with isoflurane
Levels of HIF1-ALPHA mRNA and miR-155 were measured by Q RT-PCR ( Figure 7A, 7B) . HIF1-ALPHA protein in lung tissue after LPS induction of ALI was determined by western blot and immunohistochemistry after 4 h isoflurane treatment ( Figure 7C, 7D) . HO-1 protein was also measured by western blot ( Figure 7C ). The level of miR-155 increased significantly in LPS injection group compared with the normal control group, while decreased significantly in the group posttreated with isoflurane after challenge with LPS compared with the LPS group ( Figure 7A ). And postconditioning with isoflurane increased HIF1-ALPHA mRNA and protein levels after LPS treatment ( Figure 7B, 7C, 7D ).
Overexpression of miR-155 impaired isoflurane protection against LPS-induced injury
To explore whether isoflurane exerted a protective effect by suppressing miR-155 activity, TNF-a and IL-1β levels were measured in BALF of mice that were overexpressing or downregulating miR-155. The levels of TNF-a and IL-1β were higher in the miR-155-overexpressing group compared with mice of control group. In addition, TNF-a and IL-1β levels in BALF were lower in mice in which miR-155 was inhibited compared with mice in the control group of non-injected lentiviruses ( Figure 8A, 8B) . The results indicated that overexpression of miR-155 impaired the isoflurane protection against LPSinduced injury, while inhibition of miR-155 reduced the inflammatory reaction and promoted the isoflurane protection against LPS-induced injury.
DISCUSSION
In this study, we demonstrated that isoflurane induced cell proliferation and postconditioning with moderate isoflurane attenuated LPS-induced cell injury and inflammatory in ALI after LPS challenge. The attenuation was due to upregulation of HIF-1a through suppression of miR-155. Knocking down HIF-1a with siRNA abrogated the protective effect that isoflurane had on LPS-induced cell injury. We showed that miR-155 was sensitive to isoflurane in LPStreated cells and reduced significantly compared with the LPS-treated cells without isoflurane treatment, thereby releasing mRNA targets from its inhibitory effect. We also showed that miR-155 directly targeted HIF-1a, and downregulation of miR-155 induced the upregulation of HIF-1a during normoxia. 7 TU miR-155, miR-155 inhibitor, miR-155-EV, or miR-155 inhibitor-EV lentiviruses respectively. Fourteen days after injection, mice in each group were divided into four groups and treated as described above. The levels of TNF-a (A) and IL-1β (B) in bronchoalveolar fluid (BALF) were detected by ELISA. Mice without injection of lentiviruses (Non-injected) in each treatment group were used as controls. *p <0.05, **p <0.01 compared with Non-injected group in the same treatment method of mice © 1996-2015
Overexpression of miR-155 prevented the positive effects of isoflurane on the LPS-induced inflammatory reaction. However, when we raised the expression of miR-155 during normoxia, we did not find complete inhibition of HIF-1a, which would be supposed that HIF-1a might be also regulated by other miRNAs relating to isoflurane effects (33) . In both cells (MH-S and MLE-12) and mice treated with isoflurane, HO-1, a gene downstream of HIF-1a, increased expression according to western blot results. These results indicated that isoflurane exerted protective effects through a pathway involving miR-155, HIF-1a, and HO-1.
Isoflurane protects against LPS-induced dysfunction in crucial organs including the lung and brain (34) (35) (36) (37) . Isoflurane postconditioning reduces the release of systemic cytokines such as TNF-a and IL-1β in rats (21) . The anti-inflammatory effect of isoflurane was associated with upregulation of HIF-1a. HIF-1a is a critical transcription factor in modulating innate immunity in the lung (38, 39) . The present study showed that after dealing with LPS, isoflurane, as a nonhypoxic mediator, induced HIF-1a protein expression. When cell or lung stimulated with LPS, reactive oxygen species (ROS) were generated for eradicating bacteria and other pathogens (40) . It was demonstrated that ROS upregulated the induction of HIF-1a gene transcription involving in phosphatidylinositol 3-kinase-Akt/Protein kinase C/Histone deacetylase pathway (41) . Hence, the induction of HIF-1a might partially dependent on ROS for immune reaction when challenged with LPS. HIF-1a is reported to exert a cytoprotective effect by regulating downstream genes (42) . In a HIF-1a-deficient model, macrophages showed dysfunctional bacterial killing and sustained inflammation (43) . We previously reported that isoflurane posttreatment improved cecal ligation and puncture (CLP)-induced ALI by increasing expression of HO-1, a gene downstream of HIF-1a (20) . HO-1 mediates the protective effect of isoflurane and blocks the release of TNF-a in LPS-stimulated macrophages (22) . In this study, we investigated the mechanism of these findings. We found a novel regulatory mechanism in which isoflurane controlled LPS-induced inflammation by downregulating miR-155, and further inducing the expression of HIF-1a, resulting in elevation of the anti-inflammatory protein HO-1.
MiRNAs are crucial regulators of gene expression that are incorporated into RNA-induced silencing complexes (15) . In our study, HIF-1a was proved as a target gene of miR-155. Transfection with miR-155 or miR-155 inhibitors significantly affected HIF-1a mRNA and protein levels in MH-S and MLE-12 cells, indicating that miR-155 regulated HIF-1a posttranscriptional expression. The importance of miR-155 in isoflurane regulation of inflammation was confirmed by upregulating or knocking down miR-155 expression. After treating with isoflurane, mice injected with miR-155 inhibitors ameliorated LPS-induced lung injury and secreted less TNF-a and IL-1β compared with control mice. Overexpressing miR-155 blocked the protective effect of isoflurane, resulting in higher levels of cytokines in BALF.
HIF-1a regulates downstream genes such as HO-1 by binding to hypoxia responsive elements. Our functional studies revealed that HO-1 expression was upregulated by LPS stimulation. As an isozyme of the rate-limiting enzyme in heme oxidative degradation, HO-1 has anti-inflammatory effects in LPS-induced ALI (44, 45) . Overexpression of HO-1 inhibits pro-inflammatory cytokines in LPS-induced RAW264.7 cells (22) . In our study, we found that HO-1 protein decreased significantly in cells treated with siRNA HIF-1a when stimulating with LPS with or without isoflurane exposure. Overexpressing miR-155 reduced induction of HO-1 by isoflurane, consistent with results with HIF-1a. These data illustrated that isoflurane postconditioning attenuated LPS-induced ALI and cell injury by targeting signaling through miR-155, HIF-1a, and HO-1.
A potential limitation of our study was that respiratory physiological characteristics of mice might be altered by isoflurane conditioning. However, our previous study showed that preconditioning with 1 MAC of inhalation agent alone did not affect the acid-base status or parameters of arterial blood gases (23) .
As a pivotal regulator of inflammation, miR-155 has numerous target genes involved in immune function such as SOCS1 and SHIP-1, two crucial antiinflammatory regulators (46, 47) . Previous studies demonstrated that miR-155 attenuates the TLR signal by targeting SOCS1 and blocks the TLR4 signal by reducing SHIP-1 (48, 49) . Thus, isoflurane might also have anti-inflammatory effects by regulating SOCS1 or SHIP-1. Further investigations should be performed to explore potential mechanisms.
In summary, our investigation demonstrated that isoflurane posttreatment at 1 MAC for 4 hours
